Your browser doesn't support javascript.
loading
Head-to-head comparison of plasma p-tau181, p-tau231 and glial fibrillary acidic protein in clinically unimpaired elderly with three levels of APOE4-related risk for Alzheimer's disease.
Snellman, Anniina; Ekblad, Laura L; Ashton, Nicholas J; Karikari, Thomas K; Lantero-Rodriguez, Juan; Pietilä, Elina; Koivumäki, Mikko; Helin, Semi; Karrasch, Mira; Zetterberg, Henrik; Blennow, Kaj; Rinne, Juha O.
Afiliación
  • Snellman A; Turku PET Centre, University of Turku, Turku University Hospital, Turku, Finland; Department of Psychiatry and Neurochemistry, Institute of Neuroscience & Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden. Electronic address: anniina.snellman@utu.fi.
  • Ekblad LL; Turku PET Centre, University of Turku, Turku University Hospital, Turku, Finland.
  • Ashton NJ; Department of Psychiatry and Neurochemistry, Institute of Neuroscience & Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; Centre for Age-Related Medicine, Stavanger University Hospital, Stavanger, Norway; Department of Old Age Psychiatry, Maurice Wohl Clinica
  • Karikari TK; Department of Psychiatry and Neurochemistry, Institute of Neuroscience & Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA.
  • Lantero-Rodriguez J; Department of Psychiatry and Neurochemistry, Institute of Neuroscience & Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
  • Pietilä E; Turku PET Centre, University of Turku, Turku University Hospital, Turku, Finland.
  • Koivumäki M; Turku PET Centre, University of Turku, Turku University Hospital, Turku, Finland.
  • Helin S; Turku PET Centre, University of Turku, Turku University Hospital, Turku, Finland.
  • Karrasch M; Department of Psychology, Åbo Akademi University, Turku, Finland.
  • Zetterberg H; Department of Psychiatry and Neurochemistry, Institute of Neuroscience & Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden; UK Dementia Research Institute at UCL, London, UK;
  • Blennow K; Department of Psychiatry and Neurochemistry, Institute of Neuroscience & Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
  • Rinne JO; Turku PET Centre, University of Turku, Turku University Hospital, Turku, Finland; InFLAMES Research Flagship Center, University of Turku, Turku, Finland.
Neurobiol Dis ; 183: 106175, 2023 07.
Article en En | MEDLINE | ID: mdl-37268240
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Alzheimer / Disfunción Cognitiva Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Aged / Humans Idioma: En Revista: Neurobiol Dis Asunto de la revista: NEUROLOGIA Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Alzheimer / Disfunción Cognitiva Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Aged / Humans Idioma: En Revista: Neurobiol Dis Asunto de la revista: NEUROLOGIA Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos